Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management

Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance. The disorder is manifest by hyperphosphatemia, inappropriately increased tubular reabsorption of phosphate and 1,25-dihydroxy-Vitamin D, and ectopic...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyce, Alison M., Lee, Alisa E., Roszko, Kelly L., Gafni, Rachel I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225339/
https://www.ncbi.nlm.nih.gov/pubmed/32457699
http://dx.doi.org/10.3389/fendo.2020.00293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225339/
https://www.ncbi.nlm.nih.gov/pubmed/32457699
http://dx.doi.org/10.3389/fendo.2020.00293

Ejemplares similares